±ÙÄ¡Àû Àü¸³¼±ÀûÃâ¼ú ÈÄ »ýÈÇÐÀû Àç¹ßÀÇ ¿¹ÃøÀÎÀÚ·Î Epidermal Growth Factor ReceptorÀÇ ¹ßÇö: ÀüÇâÀû ¿¬±¸
Epidermal Growth Factor Receptor as Predicting Factor on Biochemical Recurrence after Radical Prostatectomy: A Prospective Study
ÀÌÁ¤¿ì, Á¤À翵, ÇÑ°æ¼®, ¼È£°æ, Á¤Áø¼ö, ÀÌ°Çö, ¹Ú¿ø¼, Á¶°¼ö, ±èÀº°æ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤¿ì ( Lee Jeong-Woo )
¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¤À翵 ( Jeong Jae-Young )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â°ú
ÇÑ°æ¼® ( Han Kyung-Seok )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â°ú
¼È£°æ ( Seo Ho-Kyung )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â°ú
Á¤Áø¼ö ( Chung Jin-soo )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â°ú
ÀÌ°Çö ( Lee Kang-Hyun )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â°ú
¹Ú¿ø¼ ( Park Weon-Seo )
±¹¸³¾Ï¼¾ÅÍ º´¸®°ú
Á¶°¼ö ( Cho Kang-Su )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±âÁ¾¾çŬ¸®´Ð
±èÀº°æ ( Kim Eun-Kyoung )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±âÁ¾¾çŬ¸®´Ð
KMID : 0358320080490110974
Abstract
Purpose: We investigated epidermal growth factor receptor(EGFR) expression in prostate cancer(PCa) and their potential role as predicting factor on biochemical recurrence(BCR).
Materials and Methods: Between February 2005 and February 2007, EGFR expression were prospectively evaluated in a consecutive series of 88 PCa patients with the following characteristics: 66 patients treated with retropubic radical prostatectomy(RRP); 22 patients treated with neoadjuvant hormonal therapy followed by RRP. The relationship between EGFR expression and several clinicopathologic parameters were evaluated. The probability of BCR-free survival was determined using the Kaplan-Meier method.
Results: EGFR expression, was evaluated by immunohistochemistry, was found in 31 of 88(35.2%) patients. 8 of 31 EGFR-positive patients(25.8%) had BCR, whereas only 5 of 57 EGFR-negative patients(8.8%) had BCR (p=0.031) during a median follow-up of 21 months. Among several variables, high serum prostate-specific antigen values(¡Ã20), extraprostatic extension, seminal vesicle invasion, and EGFR expression were the significant predictors of BCR on univariate analysis. But, multivariate analysis showed that no variable was significant predictor of BCR. EGFR-negative patients had a significantly longer mean BCR-free survival time than EGFR-positive patients(p=0.027).
Conclusions: EGFR expression could be an potential predicting factor on BCR following RRP.
Å°¿öµå
Epidermal growth factor receptor;Prostate cancer;Biochemical recurrence
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸